Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) Target Price at $42.20

Shares of Omnicell, Inc. (NASDAQ:OMCL) have earned a consensus rating of “Hold” from the six research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $42.20.

Several equities analysts have commented on OMCL shares. Benchmark restated a “buy” rating and issued a $38.00 price target on shares of Omnicell in a research note on Tuesday, April 30th. StockNews.com upgraded shares of Omnicell from a “hold” rating to a “buy” rating in a research note on Monday, July 8th.

Institutional Investors Weigh In On Omnicell

Institutional investors have recently modified their holdings of the company. Neo Ivy Capital Management purchased a new stake in Omnicell in the third quarter valued at $78,000. EntryPoint Capital LLC lifted its position in Omnicell by 121.2% in the first quarter. EntryPoint Capital LLC now owns 2,455 shares of the company’s stock valued at $72,000 after acquiring an additional 1,345 shares during the last quarter. CWM LLC lifted its position in Omnicell by 68.2% in the second quarter. CWM LLC now owns 3,048 shares of the company’s stock valued at $83,000 after acquiring an additional 1,236 shares during the last quarter. Benjamin Edwards Inc. lifted its position in Omnicell by 36.4% in the first quarter. Benjamin Edwards Inc. now owns 3,253 shares of the company’s stock valued at $95,000 after acquiring an additional 868 shares during the last quarter. Finally, Hsbc Holdings PLC purchased a new stake in Omnicell in the third quarter valued at $200,000. 97.70% of the stock is owned by hedge funds and other institutional investors.

Omnicell Stock Performance

NASDAQ:OMCL opened at $26.55 on Friday. The company has a fifty day simple moving average of $29.13 and a two-hundred day simple moving average of $29.67. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.13 and a current ratio of 2.38. Omnicell has a 52 week low of $25.12 and a 52 week high of $75.07.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, May 2nd. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.31) by $0.17. The business had revenue of $246.15 million during the quarter, compared to the consensus estimate of $235.70 million. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. Sell-side analysts predict that Omnicell will post 0.2 earnings per share for the current year.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.